Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. 19-Nor-DHEA has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
A 19-nor prohormone is designed to convert downstream toward 19-nortestosterone, but a share of any androgen pool is also aromatised to oestrogens. DIM shifts oestradiol metabolism toward 2-hydroxy metabolites by inducing CYP1A1. That is why the pair shows up together, and it is a metabolism argument rather than a demonstrated outcome.
Steroid hormones and their metabolites are cleared as glucuronide conjugates. Calcium D-glucarate inhibits gut beta-glucuronidase, so fewer conjugates are deconjugated and reabsorbed. The mechanism is real; whether it meaningfully changes circulating steroid levels at supplement doses has not been established.
Zinc is structurally required by the androgen receptor's DNA-binding domain and by multiple steroid-metabolising enzymes. In frank deficiency, androgen signalling is impaired regardless of substrate supply. Correcting a deficiency is not the same as adding zinc on top of adequate status, and only the first has support.
Oral prohormones pass through the liver at high concentration and are associated with shifts in lipid panels and liver enzymes. Silymarin is routinely stacked on that basis. The pairing is convention among users, not something that has been tested as a protective strategy for this compound.
Small human studies report that boron intake shifts sex hormone-binding globulin, which changes the free fraction of circulating androgens rather than the total. A change in a binding protein is a marker shift, not an outcome. The interaction with a 19-nor precursor specifically has never been examined.
Exogenous androgen precursors suppress endogenous gonadotropin output through negative feedback, and ashwagandha is used with an eye to the same axis from the other direction. Combining them means two inputs to one feedback loop, so the net effect is not predictable from either alone. Worth flagging rather than assuming additive.
Observational data links low vitamin D status with lower circulating testosterone in men, and intervention results are mixed. An association is not a cause, and no study has combined vitamin D with a 19-nor prohormone. Read this as background rather than a stack recommendation.
Nothing specific on file for 19-Nor-DHEA. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 2 we read for 19-Nor-DHEA. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.